Literature DB >> 1535339

Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

P J Baker1, T Hraba, C E Taylor, K R Myers, K Takayama, N Qureshi, P Stuetz, S Kusumoto, A Hasegawa.   

Abstract

Lipid A preparations derived from the lipopolysaccharides of several gram-negative bacteria, as well as chemically defined synthetic lipid A's and their analogs (both glucosamine mono- and disaccharides), were used to establish the chemical structures required for (i) abolishing the expression of suppressor T cell (Ts) function and (ii) inducing polyclonal activation of B cells. Salmonella minnesota R595 lipid A (diphosphoryl lipid A) possesses both of these activities. Decreasing the number of phosphate groups in lipid A from two to one (monophosphoryl lipid A) as well as decreasing the fatty acyl content, primarily by removing the residue at the 3 position, resulted in a progressive reduction in toxicity; however, these structural modifications did not influence its ability to abolish the expression of Ts function. Reducing the fatty acyl content from five to four (lipid A precursor IVA or Ia) eliminated the capacity to influence Ts function but not to induce polyclonal activation of B cells. None of the monosaccharide analogs of lipid A examined influenced the expression of Ts activity, although some were able to activate B cells polyclonally. Thus, in order to be able to abolish the expression of Ts function, lipid A (i) must be a glucosamine disaccharide, (ii) may have either one or two phosphate groups, and (iii) must have at least five fatty acyl groups. Also, the chain length of the nonhydroxylated fatty acid, as well as the location of acyloxyacyl groups (2' versus 3' position), may play an important role. These findings indicate that the chemical structures responsible for the toxicity of lipid A differ from those that influence its capacity to abolish the expression of Ts function and to induce polyclonal activation of B cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535339      PMCID: PMC257223          DOI: 10.1128/iai.60.7.2694-2701.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.

Authors:  J M Jones; D F Amsbaugh; P W Stashak; B Prescott; P J Baker; D W Alling
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

Review 2.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 3.  Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action.

Authors:  M A Freudenberg; C Galanos
Journal:  Int Rev Immunol       Date:  1990       Impact factor: 5.311

4.  Effect of splenectomy on the expression of regulatory T cell activity.

Authors:  D F Amsbaugh; B Prescott; P J Baker
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

5.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

8.  Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.

Authors:  F S Ekwunife; C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

9.  Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A.

Authors:  P J Baker; K R Haslov; M B Fauntleroy; P W Stashak; K Myers; J T Ulrich
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

10.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens.

Authors:  J R McGhee; J J Farrar; S M Michalek; S E Mergenhagen; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

View more
  9 in total

1.  Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.

Authors:  H Loppnow; F Stelter; U Schönbeck; C Schlüter; M Ernst; C Schütt; H D Flad
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

2.  Reversal of lipopolysaccharide-analog-induced antibody suppression by anti-transforming growth factor beta and indomethacin.

Authors:  M J Odean; A G Johnson; M Mohrman; A Hasegawa
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  L-rhamnose inhibits proliferation of murine splenocytes by the lipopolysaccharide and polysaccharide moiety of Shigella dysenteriae type 1 lipopolysaccharide.

Authors:  T Biswas; S Roy; K K Banerjee
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

6.  Modulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431.

Authors:  C L Manthey; P Y Perera; N Qureshi; P L Stütz; T A Hamilton; S N Vogel
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharides.

Authors:  Yaning Han; Ye Li; Jiuzhou Chen; Yanzhen Tan; Feng Guan; Xiaoyuan Wang
Journal:  Mar Drugs       Date:  2013-01-31       Impact factor: 5.118

8.  Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A.

Authors:  Biwen Wang; Yaning Han; Ye Li; Yanyan Li; Xiaoyuan Wang
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 9.  The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology.

Authors:  Arturo Orlacchio; Pellegrino Mazzone
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.